Our Mission

The Robert M. Berne Cardiovascular Research Center was established to expand basic, translational, and clinical research of cardiovascular diseases. Cardiovascular diseases, including congestive heart failure, hypertension, atherosclerosis, stroke, aneurysms, and vascular auto-immune diseases are the most common cause of death and disability in the United States, and account for approximately 30% of deaths and health care costs annually in this country and developed societies.

The mission of the Robert M. Berne Cardiovascular Research Center is to support interdisciplinary research in basic, translational and clinical cardiovascular sciences, including cardiovascular development, function, pathophysiology, pharmacology, genetics, genomics, and proteomics, and to apply this knowledge to better understand the causes of cardiovascular diseases and to pioneer development of new innovative therapies and approaches to prevent or treat them.

Goals and Objectives

  • To support basic, translational, and clinical research that can be translated into therapies and improve patient care
  • To provide resources that enhance research in cardiovascular related diseases
  • To disseminate knowledge by lectures, seminars and other educational opportunities
  • To support training of pre- and postgraduate students, residents and fellows in the cardiovascular sciences and cardiovascular medicine
  • To help integrate cardiovascular research across labs, departments, and schools at UVA as well as with outside institutions including facilitating collaborative studies
  • To assist CVRC investigators in developing a plan for translating research findings into products or procedures that benefit patients including providing advice on protecting intellectual property, establishing biotech startup companies, and licensing technology to companies


MR5 Room 1005,

Camilla Wenceslau, Ph.D., M.S., FAHA

Hypertension Compromises Tissue-Resident Endothelial Progenitor Cells, Driving Impaired Vascular Regeneration and Highlighting Partial Reprogramming as a Therapeutic Strategy I will present some preliminary data demonstrating a reduction in tissue-resident endothelial progenitor cells (EPCs) in hypertensive animals. I will show that … Read More

Find out more
MR5 Room 3005,

Gary Owens, PhD

Dichotomous Roles of Inflammation in Atherosclerosis Thromboembolic events secondary to rupture or erosion of advanced atherosclerotic lesions are the underlying cause of heart attacks and stroke which are the leading cause of death in the United States and worldwide. Whereas … Read More

Find out more
Pinn Hall Conference Center Auditorium,